Published in Blood Weekly, August 28th, 2008
"One hundred forty-four patients were eligible for this retrospective analysis; 99 had MO and 45 M1a disease. The median radiation dose was 50.4 Gy for patients receiving both neoadjuvant and definitive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.